Asia-Pacific Orthobiologics Market by Type (Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation), by End-User (Hospitals, Point-of-Care Testing) – Forecast to 2019

“The Asian orthobiologics market is expected to present significant growth opportunities for its stakeholders. This market was valued at $1,181.9 million in 2014 and is estimated to reach $1,651.6 million by 2019, at a CAGR of 6.9% from 2014 to 2019.
Browse through the TOC of the Asian orthobiologics market, to get an idea of the market segmentation and the in-depth analysis provided in this report.
http://www.micromarketmonitor.com/market/asia-orthobiologics-7943449547.html
The increasing demand for biological implants over mechanical implants, coupled with the rising awareness levels about the benefits of orthobiologics, is driving the growth of this market. Moreover, the rising demand for orthopedic devices is also contributing to the growth of the Asian orthobiologics market. The orthobiologics market has seen impressive growth since 2012 owing to the increase in the number of research and development activities in this field as well as the rising demand for orthobiologics due to the various benefits associated with their use.
Japan accounts for the largest share of the Asian orthobiologics market. The market in this geographic segment is slated to grow further due to the augmented growth in research, and the growth in aging population in the country. The market in India is expected to witness the highest growth owing to the rising geriatric population and increasing number of road accidents in the country.
The Asian orthobiologics market is segmented and forecasted based on products and end users. Based on geography, the market has been segmented into Japan, China, India, Republic of Korea, and the Rest of Asia (RoA). This report also includes the market share, value chain analyses, and market metrics such as drivers, restraints, and upcoming opportunities. In addition, it presents a competitive landscape and company profiles of key players operating in the Asian orthobiologics market.

”

“TABLE OF CONTENTS

1 INTRODUCTION 11
1.1 OBJECTIVES OF THE STUDY 11
1.2 MARKET SEGMENTATION & COVERAGE 12
1.3 STAKEHOLDERS 12
2 RESEARCH METHODOLOGY 13
2.1 INTEGRATED ECOSYSTEM OF THE ORTHOBIOLOGICS MARKET 14
2.1.1 TOP-DOWN APPROACH 14
2.1.2 BOTTOM-UP APPROACH 16
2.1.3 MACROINDICATOR-BASED APPROACH 17
2.2 ASSUMPTIONS 18
3 EXECUTIVE SUMMARY 19
4 MARKET OVERVIEW 21
4.1 INTRODUCTION 21
4.2 ASIA ORTHOBIOLOGICS MARKET: COMPARISON WITH PARENT MARKET 22
4.3 MARKET DRIVERS AND INHIBITORS 22
4.4 KEY MARKET DYNAMICS 24
5 ASIA ORTHOBIOLOGICS MARKET, BY PRODUCT 25
5.1 INTRODUCTION 26
5.2 ASIA ORTHOBIOLOGICS MARKET, BY PRODUCT: COMPARISON WITH ORTHOPEDIC DEVICES MARKET 27
5.3 ASIA: BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY 28
5.4 ASIA: BONE ALLOGRAFTS MARKET, BY COUNTRY 29
5.5 ASIA: VISCOSUPPLEMENTATION MARKET, BY COUNTRY 30
5.6 ASIA: STEM CELL THERAPY MARKET, BY COUNTRY 31
5.7 ASIA: BONE GROWTH FACTOR AND SPINAL STIMULATION MARKET, BY COUNTRY 32
6 ASIA ORTHOBIOLOGICS MARKET, BY END USER 33
6.1 INTRODUCTION 34
6.2 ASIA: HOSPITALS MARKET, BY COUNTRY 35
6.3 ASIA: ORTHOPEDIC CLINICS MARKET, BY COUNTRY 36
6.4 ASIA: OTHER END-USERS MARKET, BY COUNTRY 37

7 ASIA ORTHOBIOLOGICS MARKET, BY COUNTRY 38
7.1 INTRODUCTION 39
7.2 JAPAN: ORTHOBIOLOGICS MARKET 40
7.2.1 JAPAN: ORTHOBIOLOGICS MARKET, BY PRODUCT 41
7.2.2 JAPAN: ORTHOBIOLOGICS MARKET, BY END USER 42
7.3 CHINA: ORTHOBIOLOGICS MARKET 44
7.3.1 CHINA: ORTHOBIOLOGICS MARKET, BY PRODUCT 44
7.3.2 CHINA: ORTHOBIOLOGICS MARKET, BY END USER 46
7.4 INDIA: ORTHOBIOLOGICS MARKET 47
7.4.1 INDIA: ORTHOBIOLOGICS MARKET, BY PRODUCT 48
7.4.2 INDIA: ORTHOBIOLOGICS MARKET, BY END USER 49
7.5 REPUBLIC OF KOREA: ORTHOBIOLOGICS MARKET 51
7.5.1 REPUBLIC OF KOREA: ORTHOBIOLOGICS MARKET, BY PRODUCT 52
7.5.2 REPUBLIC OF KOREA: ORTHOBIOLOGICS MARKET, BY END USER 53
8 ASIA ORTHOBIOLOGICS MARKET: COMPETITIVE LANDSCAPE 55
8.1 ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS 55
8.2 COMPANY PRESENCE IN ORTHOBIOLOGICS MARKET, BY PRODUCT 56
8.3 MERGERS & ACQUISITIONS 57
8.4 NEW PRODUCT LAUNCHES 58
8.5 EXPANSIONS 59
8.6 AGREEMENTS 60
8.7 OTHER DEVELOPMENTS 60
9 ASIA ORTHOBIOLOGICS MARKET, BY COMPANY 61
(Overview, Financials, Products & Services, Strategy, and Developments)*
9.1 BIOMET, INC. 61
9.2 MEDTRONIC PLC 64
9.3 INTEGRA LIFE SCIENCES CORPORATION 67
9.4 STRYKER CORPORATION 71
9.5 ZIMMER, INC. 74
9.6 DEPUY SYNTHES (PART OF JOHNSON & JOHNSON) 77
9.7 TORNIER, INC. 81
9.8 NUVASIVE, INC. 84
9.9 EXACTECH, INC. 86
9.10 GLOBUS MEDICAL INC. 89
9.11 WRIGHT MEDICAL TECHNOLOGY, INC. 92
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
10 APPENDIX 96
10.1 CUSTOMIZATION OPTIONS 96
10.1.1 REGULATORY FRAMEWORK 96
10.1.2 EPIDEMIOLOGY DATA 96
10.1.3 SURGEONS/PHYSICIANS PERCEPTION ANALYSIS 96
10.1.4 IMPACT ANALYSIS 96
10.2 RELATED REPORTS 97
10.3 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 98
10.3.1 RT SNAPSHOTS 99

 
“
“LIST OF TABLES

UU
TABLE 1 ASIA ORTHOBIOLOGICS PEER MARKET SIZE, 2014 (USD MN) 15
TABLE 2 ASIA ORTHOBIOLOGICS MARKET: MACROINDICATORS, BY COUNTRY, 2014 17
TABLE 3 ASIA ORTHOBIOLOGICS MARKET: COMPARISON WITH PARENT MARKET, 
2013 – 2019 (USD MN) 22
TABLE 4 ASIA ORTHOBIOLOGICS MARKET: DRIVERS AND INHIBITORS 22
TABLE 5 ASIA ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013 – 2019 (USD MN) 24
TABLE 6 ASIA: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013 – 2019 (USD MN) 26
TABLE 7 ASIA ORTHOBIOLOGICS MARKET, BY PRODUCT: COMPARISON WITH PARENT MARKET, 2013–2019 (USD MN) 27
TABLE 8 ASIA: BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY, 2013–2019 (USD MN) 28
TABLE 9 ASIA: BONE ALLOGRAFTS MARKET, BY COUNTRY, 2013 – 2019 (USD MN) 29
TABLE 10 ASIA: VISCOSUPPLEMENTATION MARKET, BY COUNTRY, 2013 – 2019 (USD MN) 30
TABLE 11 ASIA: STEM CELL THERAPY MARKET, BY COUNTRY, 2013 – 2019 (USD MN) 31
TABLE 12 ASIA: BONE GROWTH FACTOR AND SPINAL STIMULATION MARKET, BY COUNTRY, 2013–2019 (USD MN) 32
TABLE 13 ASIA: ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2013 – 2019 (USD MN) 34
TABLE 14 ASIA: HOSPITALS MARKET SIZE, BY COUNTRY, 2013 – 2019 (USD MN) 35
TABLE 15 ASIA: ORTHOPEDIC CLINICS MARKET SIZE, BY COUNTRY, 2013 – 2019 (USD MN) 36
TABLE 16 ASIA: OTHER END-USERS MARKET, BY COUNTRY, 2013 – 2019 (USD MN) 37
TABLE 17 ASIA: ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2013 – 2019 (USD MN) 39
TABLE 18 JAPAN: ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT, 2013-2019 (USD MN) 41
TABLE 19 JAPAN: ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2013 – 2019 (USD MN) 43
TABLE 20 CHINA: ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT, 2013 – 2019 (USD MN) 45
TABLE 21 CHINA: ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2013 – 2019 (USD MN) 46
TABLE 22 INDIA: ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT, 2013 – 2019 (USD MN) 48
TABLE 23 INDIA: ORTHOBIOLOGICS MARKET, BY END USER, 2013 – 2019 (USD MN) 50
TABLE 24 REPUBLIC OF KOREA: ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT, 
2013 – 2019 (USD MN) 52
TABLE 25 REPUBLIC OF KOREA: ORTHOBIOLOGICS MARKET, BY END USER, 
2013 – 2019 (USD MN) 54
TABLE 26 ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS, 2013 (%) 55
TABLE 27 ASIA ORTHOBIOLOGICS MARKET: MERGERS & ACQUISITIONS 57
TABLE 28 ASIA ORTHOBIOLOGICS MARKET: NEW PRODUCT LAUNCHES 58
TABLE 29 ASIA ORTHOBIOLOGICS MARKET: EXPANSIONS 59
TABLE 30 ASIA ORTHOBIOLOGICS MARKET: AGREEMENTS 60
TABLE 31 ASIA ORTHOBIOLOGICS MARKET: OTHER DEVELOPMENTS 60
TABLE 32 BIOMET, INC.: KEY FINANCIALS, 2011 – 2013 (USD MN) 62
TABLE 33 MEDTRONIC, PLC.: KEY FINANCIALS, 2009 – 2013 (USD MN) 64
TABLE 34 INTEGRA LIFE SCIENCES CORPORATION: KEY FINANCIALS, 2010 – 2013 (USD MN) 68
TABLE 35 STRYKER CORPORATION: KEY FINANCIALS, 2009 – 2013 (USD MN) 72
TABLE 36 ZIMMER, INC.: KEY FINANCIALS, 2009 – 2013 (USD MN) 75
TABLE 37 DEPUY SYNTHES: KEY FINANCIALS, 2011 – 2013 (USD MN) 78
TABLE 38 TORNIER, INC.: KEY FINANCIALS, 2009 – 2013 (USD MN) 82
TABLE 39 NUVASIVE, INC.: KEY FINANCIALS, 2009 – 2013 (USD MN) 84
TABLE 40 EXACTECH, INC.: KEY FINANCIALS, 2009 -2013 (USD MN) 87
TABLE 41 GLOBUS MEDICAL, INC.: KEY FINANCIALS, 2009 -2013 (USD MN) 89
TABLE 42 WRIGHT MEDICAL TECHNOLOGY, INC.: KEY FINANCIALS, 2011-2013 (USD MN) 92

 
“
“LIST OF FIGURES

FIGURE 1 ASIA ORTHOBIOLOGICS MARKET: SEGMENTATION & COVERAGE 12
FIGURE 2 ORTHOBIOLOGICS MARKET: INTEGRATED ECOSYSTEM 14
FIGURE 3 TOP-DOWN APPROACH 15
FIGURE 4 BOTTOM-UP APPROACH 16
FIGURE 5 MACROINDICATOR-BASED APPROACH 17
FIGURE 6 ASIA ORTHOBIOLOGICS MARKET SNAPSHOT 20
FIGURE 7 ASIA ORTHOBIOLOGICS PRODUCTS MARKET, BY COUNTRY, 2014 (USD MN) 24
FIGURE 8 ASIA: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013 – 2019 (USD MN) 26
FIGURE 9 ASIA ORTHOBIOLOGICS MARKET, BY PRODUCT: COMPARISON WITH ORTHOPEDIC DEVICES MARKET, 2013–2019 (USD MN) 27
FIGURE 10 ASIA: BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY, 2013–2019 (USD MN) 28
FIGURE 11 ASIA: BONE ALLOGRAFTS MARKET, BY COUNTRY, 2013 – 2019 (USD MN) 29
FIGURE 12 ASIA: VISCOSUPPLEMENTATION MARKET, BY COUNTRY, 2013 – 2019 (USD MN) 30
FIGURE 13 ASIA: STEM CELL THERAPY MARKET, BY COUNTRY, 2013 – 2019 (USD MN) 31
FIGURE 14 ASIA: BONE GROWTH FACTOR AND SPINAL STIMULATION MARKET, BY COUNTRY, 2013–2019 (USD MN) 32
FIGURE 15 ASIA: ORTHOBIOLOGICS MARKET, BY END USER, 2013 – 2019 (USD MN) 34
FIGURE 16 ASIA: HOSPITALS MARKET, BY COUNTRY, 2013 – 2019 (USD MN) 35
FIGURE 17 ASIA: ORTHOPEDIC CLINICS MARKET, BY COUNTRY, 2013 – 2019 (USD MN) 36
FIGURE 18 ASIA: OTHER END-USERS MARKET, BY COUNTRY, 2013 – 2019 (USD MN) 37
FIGURE 19 ASIA: ORTHOBIOLOGICS MARKET GROWTH ANALYSIS, BY COUNTRY, 
2014-2019 (USD MN) 39
FIGURE 20 JAPAN: ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%) 40
FIGURE 21 JAPAN: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 41
FIGURE 22 JAPAN: ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT 42
FIGURE 23 JAPAN: ORTHOBIOLOGICS MARKET, BY END USER, 2013 – 2019 (USD MN) 42
FIGURE 24 JAPAN: ORTHOBIOLOGICS MARKET SHARE, BY TYPE, 2014 & 2019 (%) 43
FIGURE 25 CHINA: ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%) 44
FIGURE 26 CHINA: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 44
FIGURE 27 CHINA: ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT 45
FIGURE 28 CHINA: ORTHOBIOLOGICS MARKET, BY END USER, 2013 – 2019 (USD MN) 46
FIGURE 29 CHINA: ORTHOBIOLOGICS MARKET SHARE, BY END USER, 2014 & 2019 (%) 47
FIGURE 30 INDIA: ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%) 47
FIGURE 31 INDIA: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013 – 2019 (USD MN) 48
FIGURE 32 INDIA: ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT 49
FIGURE 33 INDIA: ORTHOBIOLOGICS MARKET, BY END USER, 2013 – 2019 (USD MN) 49
FIGURE 34 INDIA: ORTHOBIOLOGICS MARKET: END USER SNAPSHOT 50
FIGURE 35 REPUBLIC OF KOREA: ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%) 51
FIGURE 36 REPUBLIC OF KOREA: ORTHOBIOLOGICS MARKET, BY PRODUCT, 
2013 – 2019 (USD MN) 52
FIGURE 37 REPUBLIC OF KOREA: ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT 53
FIGURE 38 REPUBLIC OF KOREA: ORTHOBIOLOGICS MARKET, BY END USER, 
2013 – 2019 (USD MN) 53
FIGURE 39 REPUBLIC OF KOREA ORTHOBIOLOGICS MARKET: END USER SNAPSHOT 54
FIGURE 40 ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS, 2013 (%) 55
FIGURE 41 ORTHOBIOLOGICS MARKET: COMPANY PRODUCT COVERAGE, 2013 56
FIGURE 42 BIOMET, INC.: REVENUE MIX, 2013 (%) 61
FIGURE 43 CONTRIBUTION OF SPINE, BONE HEALING, & MICROFIXATION SEGMENT TO COMPANY REVENUE, 2011-2013 (USD MN) 62
FIGURE 44 MEDTRONIC, PLC. REVENUE MIX, 2013 (%) 64
FIGURE 45 CONTRIBUTION OF RESTORATIVE THERAPIES GROUP SEGMENT TO COMPANY REVENUE, 2009-2013 (USD MN) 65
FIGURE 46 INTEGRA LIFE SCIENCES CORPORATION: REVENUE MIX, 2013 (%) 67
FIGURE 47 CONTRIBUTION OF U.S. SPINE AND OTHER SEGMENT TO COMPANY REVENUE, 
2010-2013 (USD MN) 68
FIGURE 48 STRYKER CORPORATION: REVENUE MIX, 2013 (%) 71
FIGURE 49 CONTRIBUTION OF NEUROTECHNOLOGY AND SPINE SEGMENT TO COMPANY REVENUE, 2009-2013 (USD MN) 72
FIGURE 50 ZIMMER, INC.: REVENUE MIX, 2013 (%) 74
FIGURE 51 CONTRIBUTION OF SURGICAL AND OTHER SEGMENT TO COMPANY REVENUE, 
2009-2013 (USD MN) 75
FIGURE 52 DEPUY SYNTHES: REVENUE MIX, 2013 (%) 77
FIGURE 53 CONTRIBUTION OF MEDICAL DEVICES AND DIAGNOSTICS SEGMENT TO COMPANY REVENUE, 2011-2013 (USD MN) 78
FIGURE 54 TORNIER, INC.: REVENUE MIX 2013 (%) 81
FIGURE 55 CONTRIBUTION OF THE EXTREMITIES SEGMENT TO COMPANY REVENUE, 
2009-2013 (USD MN) 82
FIGURE 56 NUVASIVE, INC.: REVENUE MIX 2013 (%) 84
FIGURE 57 CONTRIBUTION OF BIOLOGICS SEGMENT TO COMPANY REVENUE, 
2009 – 2013 (USD MN) 85
FIGURE 58 EXACTECH, INC.: REVENUE MIX 2013 (%) 86
FIGURE 59 CONTRIBUTION OF BIOLOGICS & SPINE SEGMENT TO COMPANY REVENUE, 
2009 – 2013 (USD MN) 87
FIGURE 60 GLOBUS MEDICAL, INC.: REVENUE MIX 2013 (%) 89
FIGURE 61 CONTRIBUTION OF DISRUPTIVE TECHNOLOGY SEGMENT TO COMPANY REVENUE, 2009 – 2013 (USD MN) 90
FIGURE 62 WRIGHT MEDICAL TECHNOLOGY, INC.: REVENUE MIX 2013 (%) 92
FIGURE 63 CONTRIBUTION OF BIOLOGICS SEGMENT TO COMPANY REVENUE, 
2011 – 2013 (USD MN) 93

“